Drug-resistant epilepsy with frequent seizures was common in both SCN1A and non-SCN1A cohorts, with most individuals experiencing at least monthly seizures, whilst only 6.2% across the entire cohort were seizure-free at last follow-up. Here, SCN1A is linked to epilepsy.